drugset / Trial / NCT02004197

Quadruple and Phytomedicine-based Therapies in H. Pylori Infection

NCT02004197

Phase 2/3 Completed 176 enrolled Hafiz Muhammad Asif
RandomizedParallel-groupOpen-labelTreatment

Summary

Helicobacter pylori is strongly associated to the development of gastrointestinal disorders. Emerging antibiotic resistance and poor patient compliance of modern therapies has resulted in significant eradication failure. Clinical trial was conducted to see the efficacy of current quadruple and phytomedicine-based therapies for the eradication of H. pylori infection and relief in its associated symptoms in Pakistan.

Timeline

Start
2010-01
Primary completion
2012-09
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified
Subject Metronidazole Small molecule
Subject Omeprazole Other / unclassified
Subject Pylorex plus Traditional medicine (herbal / TCM)
Subject ranitidine bismuth citrate Unknown